The Cell and Gene Therapy Catapult
Catalyses and facilitates growth in the cell and gene therapy industry.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD24—37m (Dealroom.co estimates May 2018.)
Company register number 10016023
London England (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 45.7m | 43.8m | 51.4m | 72.1m | 83.7m | 87.3m | 99.0m |
| % growth | 47 % | (4 %) | 17 % | 40 % | 16 % | 4 % | 13 % |
| EBITDA | 15.5m | 11.9m | - | - | - | - | - |
| % EBITDA margin | 34 % | 27 % | - | - | - | - | - |
| Profit | 9.1m | 4.9m | - | - | - | - | - |
| % profit margin | 20 % | 11 % | - | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
£3.0m | Early VC | ||
| N/A | N/A | Grant | |
| N/A | £3.0m | Grant | |
* | £600k | Grant | |
| Total Funding | AUD13.5m | ||